These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9019162

  • 1. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.
    Fiddes RJ, Janes PW, Sanderson GM, Sivertsen SP, Sutherland RL, Daly RJ.
    Cell Growth Differ; 1995 Dec; 6(12):1567-77. PubMed ID: 9019162
    [Abstract] [Full Text] [Related]

  • 2. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3.
    Carraway KL, Soltoff SP, Diamonti AJ, Cantley LC.
    J Biol Chem; 1995 Mar 31; 270(13):7111-6. PubMed ID: 7535767
    [Abstract] [Full Text] [Related]

  • 3. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells.
    Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N, Lupu R.
    Oncogene; 1996 Apr 18; 12(8):1679-87. PubMed ID: 8622888
    [Abstract] [Full Text] [Related]

  • 4. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M, Grijalva R, Yu D.
    Cancer Res; 1999 Apr 01; 59(7):1620-5. PubMed ID: 10197638
    [Abstract] [Full Text] [Related]

  • 5. Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins.
    Jeschke M, Wels W, Dengler W, Imber R, Stöcklin E, Groner B.
    Int J Cancer; 1995 Mar 03; 60(5):730-9. PubMed ID: 7860149
    [Abstract] [Full Text] [Related]

  • 6. Mutation of a Shc binding site tyrosine residue in ErbB3/HER3 blocks heregulin-dependent activation of mitogen-activated protein kinase.
    Vijapurkar U, Cheng K, Koland JG.
    J Biol Chem; 1998 Aug 14; 273(33):20996-1002. PubMed ID: 9694850
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.
    Fiddes RJ, Janes PW, Sivertsen SP, Sutherland RL, Musgrove EA, Daly RJ.
    Oncogene; 1998 May 28; 16(21):2803-13. PubMed ID: 9652748
    [Abstract] [Full Text] [Related]

  • 8. Replacement of N-terminal portions of TGF-alpha with corresponding heregulin sequences affects ligand-induced receptor signaling and intoxication of tumor cells by chimeric growth-factor toxins.
    Schmidt M, Wels W.
    Int J Cancer; 2002 Jan 20; 97(3):349-56. PubMed ID: 11774287
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G, Heiss P, Schlegel J, Hofstaedter F, Knuechel R.
    Cytometry; 2001 Aug 01; 44(4):338-48. PubMed ID: 11500850
    [Abstract] [Full Text] [Related]

  • 10. Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of heregulin-beta2/PE40.
    Furger C, Fiddes RJ, Quinn DI, Bova RJ, Daly RJ, Sutherland RL.
    Cancer Res; 1998 May 01; 58(9):1773-8. PubMed ID: 9581810
    [Abstract] [Full Text] [Related]

  • 11. Changes in heregulin beta1 (HRGbeta1) signaling after inhibition of ErbB-2 expression in a human breast cancer cell line.
    Yoo JY, Hamburger AW.
    Mol Cell Endocrinol; 1998 Mar 16; 138(1-2):163-71. PubMed ID: 9685225
    [Abstract] [Full Text] [Related]

  • 12. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.
    Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD, Sliwkowski MX.
    Cancer Res; 1996 Mar 15; 56(6):1457-65. PubMed ID: 8640840
    [Abstract] [Full Text] [Related]

  • 13. The influence of heregulins on human Schwann cell proliferation.
    Levi AD, Bunge RP, Lofgren JA, Meima L, Hefti F, Nikolics K, Sliwkowski MX.
    J Neurosci; 1995 Feb 15; 15(2):1329-40. PubMed ID: 7869101
    [Abstract] [Full Text] [Related]

  • 14. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
    Lee H, Akita RW, Sliwkowski MX, Maihle NJ.
    Cancer Res; 2001 Jun 01; 61(11):4467-73. PubMed ID: 11389077
    [Abstract] [Full Text] [Related]

  • 15. HER4 expression correlates with cytotoxicity directed by a heregulin-toxin fusion protein.
    Siegall CB, Bacus SS, Cohen BD, Plowman GD, Mixan B, Chace D, Chin DM, Goetze A, Green JM, Hellström I.
    J Biol Chem; 1995 Mar 31; 270(13):7625-30. PubMed ID: 7535774
    [Abstract] [Full Text] [Related]

  • 16. Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells.
    Noguchi H, Sakamoto C, Wada K, Akamatsu T, Uchida T, Tatsuguchi A, Matsui H, Fukui H, Fujimori T, Kasuga M.
    Gastroenterology; 1999 Nov 31; 117(5):1119-27. PubMed ID: 10535875
    [Abstract] [Full Text] [Related]

  • 17. Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.
    Fitzpatrick VD, Pisacane PI, Vandlen RL, Sliwkowski MX.
    FEBS Lett; 1998 Jul 10; 431(1):102-6. PubMed ID: 9684874
    [Abstract] [Full Text] [Related]

  • 18. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
    Schaefer G, Fitzpatrick VD, Sliwkowski MX.
    Oncogene; 1997 Sep 18; 15(12):1385-94. PubMed ID: 9333014
    [Abstract] [Full Text] [Related]

  • 19. Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.
    Yang C, Liu Y, Lemmon MA, Kazanietz MG.
    Mol Cell Biol; 2006 Feb 18; 26(3):831-42. PubMed ID: 16428439
    [Abstract] [Full Text] [Related]

  • 20. Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity.
    Altiok N, Altiok S, Changeux JP.
    EMBO J; 1997 Feb 17; 16(4):717-25. PubMed ID: 9049301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.